Endothelial receptor tyrosine kinases involved in angiogenesis.
about
Molecular cloning and characterization of a novel angiopoietin family protein, angiopoietin-3Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes. Implication in autocrine and paracrine regulation of angiogenesisHepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosisInhibition of vascular endothelial growth factor expression in HEC1A endometrial cancer cells through interactions of estrogen receptor alpha and Sp3 proteinsA single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cellsMULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathwayIntegrin alphavbeta3, requirement for VEGFR2-mediated activation of SAPK2/p38 and for Hsp90-dependent phosphorylation of focal adhesion kinase in endothelial cells activated by VEGFGenomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoformVascular endothelial growth factor B, a novel growth factor for endothelial cellsA novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinasesProteolytic processing regulates receptor specificity and activity of VEGF-C.Dok-R plays a pivotal role in angiopoietin-1-dependent cell migration through recruitment and activation of Pak.Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4Antiangiogenic Steroids in Human Cancer Therapy.Current targeted therapies in the treatment of advanced colorectal cancer: a reviewRoles of FGF signaling in stem cell self-renewal, senescence and agingThe vesiculo-vacuolar organelle (VVO). A new endothelial cell permeability organelleAngiopoietin-1, unlike angiopoietin-2, is incorporated into the extracellular matrix via its linker peptide regionNERF2, a member of the Ets family of transcription factors, is increased in response to hypoxia and angiopoietin-1: a potential mechanism for Tie2 regulation during hypoxiaMapping the charged residues in the second immunoglobulin-like domain of the vascular endothelial growth factor/placenta growth factor receptor Flt-1 required for binding and structural stabilityRoles of platelet factor 4 in hematopoiesis and angiogenesisThe alpha(1)beta(1) and alpha(2)beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesisFlt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in miceVascular endothelial growth factor A (VEGF-A) is involved in guidance of VEGF receptor-positive cells to the anterior portion of early embryosLong-term efficacy of ciliary muscle gene transfer of three sFlt-1 variants in a rat model of laser-induced choroidal neovascularizationVascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinaseExpression of protein kinases C betaI, betaII, and VEGF during the differentiation of enamel epithelium in tooth development.Membrane fixation of vascular endothelial growth factor receptor 1 ligand-binding domain is important for vasculogenesis and angiogenesis in mice.Vascular endothelial-cadherin tyrosine phosphorylation in angiogenic and quiescent adult tissuesInfluence of host microvascular environment on tumour vascular endothelium.Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells.HSPG-binding peptide corresponding to the exon 6a-encoded domain of VEGF inhibits tumor growth by blocking angiogenesis in murine model.Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis.Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma.Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain.Delivery of lipoplexes for genotherapy of solid tumours: role of vascular endothelial cells.Collateralization and the response to obstruction of epicardial coronary arteries.Peroxisome Proliferator-Activated Receptor Expression in Murine Models and Humans with Age-related Macular Degeneration.Markers for the lymphatic endothelium: in search of the holy grail?Autocrine VEGF signaling is required for vascular homeostasis.
P2860
Q22008784-A7BC8F8D-3DC9-4A7F-AD39-346DB2644715Q22010852-34A3BB82-4481-4637-AF21-105F7F238BE8Q22253259-F774BC79-0446-4E94-B930-F546AC248D5CQ22254113-E94BCB41-4972-4DCB-B2ED-062398F1C7D6Q24291278-948912FE-301F-474A-BADB-33008E3043ACQ24294441-8B4D85F7-5D94-4966-9A32-B41A8CAD34D0Q24306175-427E691D-1A93-4CDE-A451-507AA5F2FF78Q24311517-FC9A1A35-04A7-4C49-BEF9-DD471C775C68Q24312842-ECCEC591-6C23-4E2A-80CA-3F9F028D3383Q24336293-AA3401BB-D85B-4F29-AADD-0A9665B22D41Q24532314-143BA5DD-D382-4B23-A08D-91379DB463B2Q24535902-A27B6720-5358-4570-8464-C267684188BBQ24568018-9D4893AB-F25F-4847-87D2-30D2C4C6FE5EQ24795360-702C811D-E8FE-4A48-8587-D9B072753793Q26740067-0E1B9A06-B8C5-404E-9489-5B5B974070EEQ27025540-0ED5ED4D-FC84-426C-A053-965E57BB0637Q28205729-E4705013-1B2F-4867-BFAD-BC54C410300FQ28205770-2AE59129-79E1-4649-8ABE-5B3DEFA0DA42Q28215504-0A1AA41E-B87A-4CAB-AC83-1FA73BBE0DC2Q28260756-87EB1F3B-48AE-4C1C-9A7F-0998D33FE46FQ28294538-5AEEFBF0-A18E-4003-B863-E5B3189B64B8Q28344804-F2D311AB-109D-4FC4-8601-2AF8791510DAQ28504776-38A21DC4-A21B-4934-94AB-F1E4B81C1A30Q28506172-FF9B6593-76D0-463F-BD9C-B37877FB9F80Q28582445-B1FAD7B3-15CD-418D-9BF7-9FD7DC70889AQ28646403-DFF065B6-D658-4FBA-B792-D9006DB4344BQ31148906-CA29EB02-1AB0-41CA-B543-A82E145B754AQ33551759-17EB687B-5806-4FAC-A9BB-AA22B8A399FAQ33556970-E3287D3E-A214-4A1E-8BAE-2265D337ABD6Q33655353-B71589D4-BCCF-4F41-A0DC-6833E0DACBA5Q33689582-237D527C-7E5E-4D49-BDA7-6388C7BC5837Q33765731-FA2CE4ED-A9FE-471B-9318-044359C066E9Q33861490-3FC4AF65-2866-4D34-9581-C9F9B9A213CEQ33868284-B2C9F0F7-976B-42AC-84AD-FC856BD2C956Q33889677-F26D5139-66E2-459E-985E-877E6837B468Q34143913-3FC86E27-B743-4809-B91C-DB7A21465229Q34315287-FCA61BB2-4700-45A6-885E-FC8A3E3B1D93Q34386751-8AF66714-C4B7-446D-98BD-2785935E5C7EQ34398711-073A3D0D-E3BA-4BBD-9C53-7D9B1B100818Q34443661-59F04BE6-68BA-4AAD-9BDD-F41C3DD8FE99
P2860
Endothelial receptor tyrosine kinases involved in angiogenesis.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Endothelial receptor tyrosine kinases involved in angiogenesis.
@en
type
label
Endothelial receptor tyrosine kinases involved in angiogenesis.
@en
prefLabel
Endothelial receptor tyrosine kinases involved in angiogenesis.
@en
P2860
P921
P356
P1476
Endothelial receptor tyrosine kinases involved in angiogenesis
@en
P2093
Mustonen T
P2860
P304
P356
10.1083/JCB.129.4.895
P407
P577
1995-05-01T00:00:00Z